Archives

20
Feb

Sidney Kimmel Cancer Center Specialist Validates the Five-Tiered Gleason Grade Grouping System

Scientists have validated the contemporary five-tiered Gleason Grade Grouping using population-based data. The study, led by scientific researcher Grace Lu-Yao, PhD, Associate Director of Population Science at the Sidney Kimmel Cancer Center at Jefferson, was published in the Journal of European Urology. The research conducted confirms that the proposed five-tiered Gleason grade grouping (GGG) system is …

6
Sep

Join Team SKCC for the AACR Rock and Roll Marathon

The Sidney Kimmel Cancer Center is proud to be a 2016 Sponsor for the AACR Rock and Roll Marathon  and 5k. Our team will be competing in the 5K on Saturday September 17, 2016. Click the Link — (Team SKCC) and click the JOIN TEAM button in the right hand corner. Upon receiving a completed …

11
Aug

Dr. Nicole Simone featured in Philadelphia Inquirer

It’s always important to eat wisely, even more so when you’re sick. When it comes to cancer, however, researchers are discovering tantalizing new evidence that a patient’s diet can actually help shrink tumors. Nicole Simone, a radiation oncologist at Thomas Jefferson University’s Sidney Kimmel Cancer Center, has been studying the effect of diet on standard …

10
Aug

Monica Crawford featured in Philadelphia Inquirer: Achieving good nutrition during cancer treatments

When it comes to nutrition and cancer, most information is directed toward preventing the disease. But what  if you already have cancer and are being treated for it, whether with surgery, chemotherapy, radiation therapy, or perhaps all three? Although there have been improvements in managing side effects with medications, there are still those which remain …

5
Aug

Should You Participate in a Cancer Clinical Trial? Dr. Amy Leader & Dr. Ronald Myers Discuss

Jefferson’s Amy Leader, DrPH, MPH, and Ronald Myers, PhD, of the Division of Population Science, Department of Medical Oncology, have created a tool to help patients come to terms with their own fears and preconceptions about clinical trials, in order to help them make informed decisions about their care. A recent Philadelphia Inquirer story featured …

5
Aug

SKCC and Joe Biden Receive Atlas Awards for Leadership in Fight Against Cancer

The Vice President received the 2016 Atlas Award; the Sidney Kimmel Cancer Center received 2016 Atlas Award for Leadership in the Philadelphia Area. Jefferson medical oncologist Edith Mitchell, MD, FACP, is part of a 28-member Blue Ribbon Panel appointed to inform the scientific direction and goals of the Vice President’s National Cancer Moonshot Initiative. On …

30
Jul

Dr. Mitchell featured in US News and World Report: Stomach Cancers

Targeted treatment for a specific type of stomach cancer is “probably the most significant advancement in recent years,” says Dr. Edith Mitchell, a clinical professor of medicine and medical oncology at Thomas Jefferson University and director of the Center to Eliminate Cancer Disparities at Sidney Kimmel Cancer Center. Stomach cancers with increased levels of a …

29
Jul

Announcing our new Center of Excellence: Cancer Risk, Prevention, & Control

On behalf of Sidney Kimmel Cancer Center Leadership we are extremely excited to announce the launch of the SKCC’s first Center of Excellence (CoE) in Cancer Risk, Prevention and Control, which will be led by Dr. Veda Giri from Jefferson and Dr. Ann Klassen from Drexel University. This consortium based center will allow us to …

26
Jul

CMS Announces Jefferson Medical Oncology Associates Selected for Initiative Promoting Better Cancer Care

The Centers for Medicare & Medicaid Services (CMS) announced on June 29, 2016 that it has selected Jefferson Medical Oncology Associates (“Jefferson”) as one of nearly 200 physician group practices and 17 health insurance companies to participate in a care delivery model that supports and encourages higher quality, more coordinated cancer care. The Medicare arm …

26
Jul

Is anyone too old to be treated for cancer? Dr. Andrew Chapman

Does chemotherapy, with side effects like fatigue, skin sores, diarrhea, loss of appetite, nausea and “chemo brain” make sense for older patients? Recently, our Senior Adult Oncology Center team evaluated two cancer patients. Both had colorectal cancer that had spread to the lymph nodes and both had undergone surgery to remove the cancer.  When cancer …

25
Jul

Dr. James Posey joins the Sidney Kimmel Cancer Center

James A. Posey,III, MD, Director, Gastrointestinal Program in Medical Oncology, Co-Leader, Gastrointestinal Clinical Program at Sidney Kimmel Cancer Center, Co-Director of the Jefferson Pancreas Biliary Center Philadelphia, PA – (July 25, 2016) The Sidney Kimmel Cancer Center at Thomas Jefferson University is pleased to announce the appointment/hiring of James A. Posey III, MD as the …

20
Jul

How to Decide if Watchful Waiting is the Right Choice” Dr. Ronald Myers

A new tool helps remove the emotion around choosing the right approach for prostate cancer Over 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer. Although patients with localized, low-risk prostate cancer have treatment options: active surveillance, also called watchful …

19
Jul

A new tool helps remove the emotion around choosing the right approach for prostate cancer

How to Decide if Watchful Waiting is the Right Choice (PHILADELPHIA) – Over 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer. Although patients with localized, low-risk prostate cancer have treatment options: active surveillance, also called watchful waiting, in which …

12
Jul

Kennedy Health joins The Sidney Kimmel Cancer Network

Kennedy Health’s Cancer Center is the newest member of the Sidney Kimmel Cancer Network at Jefferson. As a cancer center network member, resources will be available to the Kennedy Cancer Center and its patients, creating local access to medical expertise, second opinions and advanced research. Learn more about the partnership. Effective July 1, Kennedy Health’s …

11
Jul

Immunotherapy for Melanoma Ignites a ‘Scientific Revolution and Promise of a Cure’

Learn more by reading a recent blog by Marlana Orloff, MD, Assistant Professor of Medical Oncology at Sidney Kimmel Medical College and researcher at Sidney Kimmel Cancer Center. “Success in melanoma has propelled the use of these drugs into many other cancers including lung, kidney, breast, pancreatic, leukemias, lymphomas, and brain, most of which remain …

29
Jun

Award of Doctor of Medical Science (Honoris Causa), University of Melbourne to Professor Richard Pestell

Dr. Pestell, was honored with the Award of Doctor of Medical Science (Honoris Causa) from the Melbourne University citing his “profound impact on the diagnosis and treatment of cancer and on the teaching, clinical, research organizations that share his determination”.  Dr. Pestell is currently one of the highest cited researcher in the world by Google …

28
Jun

Radiation Oncology Podcast Series: Hyperthermia and Thermal Oncology

Check out the lastest podcast from the Department of Radiation Oncology: Topic discussed: Enhancing the armamentarium for cancer therapy (Click Here) Contributors Hyperthermia and Thermal Oncology Adam Dicker, MD, PhD Mark Hurwitz, MD Paul Stauffer, MSEE, CCE Dario Rodrigues

27
Jun

Renée de Leeuw, PhD recevies 2016 Marjorie Katz Foundation–PCF Young Investigator Award

Prostate Cancer Foundation Announces 24 New Young Investigator Awards Class of 2016 Represents $5.4 Million Investment in the Future of Cancer CareSANTA MONICA, CA June 23, 2016 – The Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) Awards to pioneer increasingly precise treatments and faster cures for prostate cancer. Members …

24
Jun

Dr. Yang and Wang featured in Healio: MicroRNAs may predict risk for HCC in HBV

Circulating microRNAs may be used as noninvasive markers for predicting risk for developing hepatocellular carcinoma in patients with hepatitis B virus infection, according to recently published findings. “This research confirms previous work on microRNAs and liver cancer and goes further to show that these microRNAs may be able to predict the development of liver cancer …

23
Jun

Dr. Mathew Thakur Named SNMMI elected Fellow of Academy of Radiology Research Council

Nuclear Medicine and Molecular Imaging announced the creation of an SNMMI Fellowship recognizing distinguished service to SNMMI as well as exceptional achievement in the field of nuclear medicine and molecular imaging. The announcement was made during today’s Special Plenary Session at the society’s 2016 Annual Meeting, held June 11-15 in San Diego, Calif. “SNMMI Fellowship …

19
Jun

Dr. Veda Giri featured on Philly.Com: Father’s Day alert: Do you know your family cancer history?

Father’s Day is traditionally a time to honor and celebrate fatherhood. But it also can be time  for men to act and recognize the importance of knowing their family cancer history. While women are often aware of the importance of family cancer history and how genetics plays a part in cancer risk, men need to …

3
Jun

New Bladder Cancer Guidelines

Medscape Medical News recently spoke with Dr. Leonard Gomella, Chair of the Department of Urology and the Director of the Sidney Kimmel Cancer Center Network, about the new guidelines from American Urological Association (AUA) and the Society of Urologic Oncology (SUO) for managing bladder cancer*. The new guidelines affect both traditional and new therapies for …

2
Jun

Genomic Markers in Prostate Cancer

Dr. Leonard Gomella, Chair of the department of Urology and the Director of the Sidney Kimmel Cancer Center Network, was recently interviewed by Targeted Oncology about four major genomic markers used to guide treatment decisions in prostate cancer. These four genomic markers help clinicians decide between active treatment for patients with prostate cancer or active …

9
May

Radiation Oncology Podcast Series: Insights in Head and Neck Cancer: Treatment Options and Associated Toxicities.

Dr. Adam Dicker Chairman of the Department of Radiation Oncology conducts the latest Radiation Oncology podcast with Otolaryngologist Dr.  Adam Luginbuhl Key Discussions: Interest in Head & Neck Cancer His passion to reduce the toxicities of treatment His current collaborative research efforts How we resemble each other! Check out the Podcast (Click Here)

6
May

Radiation Oncology Podcast Series: In Chinese-How to be successful in US – China academic collaborations

Dr. Adam Dicker Interviews – Dr. Shi, Dr. Yu, Dr. Dicker and Dr. Ma (answers in Mandarin) (Listen Here) Our round table discussion included: How to be successful in US – China academic collaborations Entrepreneurship in US vs China A whole lot More! Dr, Shi, MD, PhD Yan Yu, PhD, MBA Xin-Ling Ma, MD, PhD

5
May

Dr. Adam Dicker featured in Oncology Times: Removing the Gag on Safety Error Reporting

Radiology has been something like a trapeze artist performing without a net. The perfected feats can be spectacular to behold, but a slip of a grip and the result can be tragic. Adam Dicker, MD, PhD, Professor and Chair of the Department of Radiation Oncology at Sidney Kimmel Medical College, and Sidney Kimmel Cancer Center …

4
May

Jefferson’s Buddy Program Gives Patients with Cancer Somebody to Lean On

                                                                                                                                                                                                                                                                                                                        Joe Lavalle, a Sidney Kimmel Cancer Center at Jefferson Buddy Program volunteer. The Sidney Kimmel Cancer Center at Jefferson Buddy Program matches patients diagnosed with prostate, breast and other types of cancer with survivors who have experienced the same or similar diagnoses, treatments and uncertainties. Their “survivor buddies” are cancer survivors ahead of them …

3
May

Dr. Leonard Gomella: “Blue light” cystoscopy for detection and treatment of non-muscle invasive bladder cancer

Dr. Leonard Gomella, MD In patients with non-muscle invasive bladder cancer, fluorescence cystoscopy can improve the detection and ablation of bladder tumors. In this paper we describe the technique and practical aspects of hexaminolevulinate (HAL) fluorescence cystoscopy, also known as “blue light cystoscopy”. Check out Dr. Gomella’s  Blue Light Video (Click Here)

27
Apr

Jefferson Harnessing “Big Data” to Broaden Cancer Research

With the help of internal and external collaborations, researchers in our Computational Medicine Center (CMC) at the Sidney Kimmel Medical College here at TJU are characterizing and analyzing the molecular drivers of several cancers, which may lead to more powerful diagnostics and personalized treatments that better target cancer’s root causes. The use of precision medicine …

26
Apr

Researchers Find Pathway that Could Make Abandoned Pancreatic Cancer Drug Effective Against the Disease

Our scientists have found that blocking one molecular pathway could make pancreatic cancer susceptible to formerly ineffective therapies. “While there’s more work to be done to confirm the results in pre-clinical models and then humans, we are encouraged by these preliminary results,” said Jonathan Brody, PhD, a researcher at our Sidney Kimmel Cancer Center and Director …

23
Apr

Dr. Gomella featured in Targeted Oncology

Experts Discuss Treatment Sequencing Strategies in CRPC As the treatment landscape for patients with metastatic castration-resistant prostate cancer (CRPC) continues to evolve, optimal strategies are becoming more apparent on how to best sequence the multitude of novel therapies that have been approved in the past decade. To gain insight into current best practices and strategies …

22
Apr

Sky Community Partners 2nd Annual Point Breeze 5K Run & Health Fair

On Saturday, April 16, 2016 Jefferson and the Sidney Kimmel Cancer Center was  pleased to partner with Sky Community Partners on their 2nd Annual Point Breeze 5k Run/Walk & Health Fair! The 5k Run/Walk  raised funds to promote and support pancreatic cancer awareness and early detection and to encourage healthy lifestyles, specifically in underserved communities. …

21
Apr

Dr. Dicker featured in Oncology Times: The Role of Genomics in Prostate Cancer Care

Fertile Genomic Ground Leads to Growth of Technology, Knowledge Laberta, Valerie As medical oncology harvests the advantages of this fertile genomic age, so do the associated therapies that benefit cancer patients. Radiation oncology has sprouted some new opportunities for improved patient care and outcomes, now ripening with the help of technology and research. Adam Dicker, …

20
Apr

Exceptional Care at the SKCC from Dr’s. Bar-Ad and Axelrod

Check out a patient story in Philadelphia Row Home Magazine. He discusses his exceptional care in the hands of the SKCC and includes the names of a number of Jefferson docs. Here’s a link to the story: https://issuu.com/philadelphiarowhomemagazine/docs/prh_spring2016v3 (Page 17 – Fight Like Hell)

15
Apr

Reimagining Patient Engagement: Jefferson-Designed Application Helps Patients Make More-Informed Shared Medical Decisions

Making decisions about healthcare options can seem overwhelming to patients and their families, and, in many cases, patients are asked to make decisions even though they have a limited understanding of their options. The Decision Counseling Program (DCP) is an online software application that enables patients to make well-informed healthcare decisions together with their treating …

11
Apr

Brittany Simone awarded AACR Travel Grant from Taconic

  Taconic Celebrates Researchers Awarded AACR Travel Grant The AACR Annual Meeting is the premier meeting for cancer research. The 2016 meeting will be held April 16-20 in New Orleans, Louisiana, USA. The program includes sessions on precision checkpoint immunotherapy, CRISPR in drug discovery, CAR T cells, immunotherapy combination treatments, and much more. Taconic has provided four …

11
Apr

High-dose radiation may be no better for low-risk prostate cancer by Dr. Robert Den

“In the field of radiation oncology, we often assume that the highest dose that the body can tolerate will be most effective at killing cancer,” said senior study author Dr. Robert Den, a researcher at Thomas Jefferson University’s Sidney Kimmel Cancer Center in Philadelphia. “Our results argue that this may not be the case, at …

8
Apr

Dr. Gomella on Current Perspectives on Prostate Cancer Screening

Leonard Gomella, MD, physician, professor, and chair of the Department of Urology at Thomas Jefferson University and director of the Sidney Kimmel Cancer Center Network, discusses the current perspectives on screening for prostate cancer. Controversy remains on screening for prostate cancer, as the United States Preventative Services Task Force advises that men should not be …

7
Apr

Radiation Oncology Podcast: Residency Program

Check out the latest Radiation Oncology podcast version 4 focusing on the Radiation Oncology residency program featuring : http://jdc.jefferson.edu/radoncjefferson/4/       Adam Dicker, MD, PhD Michael Hardin, MS, MPR2 Amy S. Harrison, MS Virginia Lockamy, PhD                     Emily Kremmel, MMP, MPR2 James Keller, PhD   …

4
Apr

Dr. Mitchell named to the Blue Ribbon Panel

Vice-President Biden’s National Cancer Moonshot Initiative Today, the National Cancer Institute (NCI), part of the National Institutes of Health, announced a Blue Ribbon Panel of scientific experts, cancer leaders, and patient advocates that will inform the scientific direction and goals at NCI of Vice President Joe Biden’s National Cancer Moonshot Initiative. The panel will serve …

1
Apr

Dr. Adam Dicker featured in OncologyNurseAdvisor

Radiotherapy/Histone Deacetylase Inhibitor Combination Safe, Effective in High-grade Gliomas Adding panobinostat to radiotherapy appears safe, tolerable, and has preliminary efficacy for treating recurrent high-grade gliomas, according to a phase 1 clinical trial published in the Journal of Neuro-Oncology. The trial combined fractionated stereotactic re-irradiation therapy (FSRT) with panobinostat.1 “We saw synergy between radiotherapy and the …

31
Mar

Conserved gene can act to inhibit lung cancer development, study finds featuring SKCC Researcher Dr. Bo Lu

Scientists believe that “conserved” genes — those found in life forms that range from bacteria to plants, insects and humans — perform vital biological functions across species. And limited research on one of those genes, Nitrilase 1 (Nit1), suggested it acts to inhibit cancer development. But researchers at Sidney Kimmel Cancer Center have found Nit1 …

30
Mar

For prostate cancer, more radiation may not improve survival featuring Dr. Robert Den

Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with …

30
Mar

Dr. Ronald Myers featured on PCORI Blog

Family Physicians Must Demystify Colorectal Cancer Screening During the nearly two decades I worked as a health correspondent for our local NBC affiliate, my cameraman was a kind, funny man who seemed to know everyone in town. Phil not only was my colleague but also my friend. PCORI’s Colorectal Cancer Focus PCORI has funded 51 …

22
Mar

Amy Callahan, DNP featured in Oncology Nursing Forum

Factors Influencing Nurses’ Use of Hazardous Drug Safe-Handling Precautions Hazardous drugs (HDs) are defined by the National Institute for Occupational Safety and Health ([NIOSH], 2004) using one or more of the following criteria: carcinogenicity, teratogenicity, reproductive toxicity, genotoxicity, organ toxicity at low doses, and drugs that mimic existing HDs in structure or toxicity. Most of …

17
Mar

Celeste Vaughn-Briggs appointed to Breast Cancer Disparities Committee

Breast Cancer Disparities Conference Susan G. Komen April 5, 2016 Philadelphia, PA Celeste Vaughan-Briggs, LCSW, Oncology Social Worker and Manager of the Free Breast and Cervical Cancer Screening Program at Thomas Jefferson University’s (Jefferson’s) Sidney Kimmel Cancer Center was invited to participate in the Roundtable discussion at the upcoming Susan G. Komen’s Breast Cancer Disparities …

16
Mar

Chief Diversity Officer Joseph Hill and Dr. Edith Mitchell featured at NMA Event

On Friday, March 4th to Sunday, March 6th, 2016, The National Medical Association held its 17th Annual Health Policy Colloquium at the Gaylord National Resort and Convention Center, National Harbor, Maryland.  This year’s theme is, “True North Toward Health Care Equity: Clinical, Policy and Social Determinants. Hundreds, from all over, gathered together for a three-day …

10
Mar

Join Team Jefferson: Komen Race for the Cure

Join the Jefferson Team and Run or Walk In The Fight Against Breast Cancer The Susan G. Komen 25th annual Race for the Cure Philadelphia Museum of Art Mother’s Day, Sunday May 8, 2016 Race Starts at 8:15 AM To register, go to www.komenphiladelphia.org/race and click register now then click join a team and search …

7
Mar

Two forms of radiosurgery for brain metastases are equally effective

With cancer spread to the brain on the rise, patients benefit from advanced techniques, say researchers at Sidney Kimmel Cancer Center (PHILADELPHIA) — While two advanced radiosurgery approaches — Gamma Knife and RapidArc® — offer different strengths, they are equally effective at eradicating cancer in the brain, say researchers at Sidney Kimmel Cancer Center. Their …

4
Mar

Jessica Teh receives 2016 AACR-Ocular Melanoma Foundation Fellowship

Jessica Teh, PhD, a Post-doctoral research fellow in the Department of Cancer Biology, Sidney Kimmel Cancer Center at Thomas Jefferson University was recently awarded the 2016 AACR-Ocular Melanoma Foundation Fellowship for her submission on, Utility of CDK4/6 inhibitors in uveal melanoma. AACR based their decision on the relevance of her application to the mission of …

Page 1 of 3